Global Amniotic Products Market

Global Amniotic Products Market by Product Type (Amniotic Suspensions and Amniotic Membranes), Type (Flowable and Non-flowable), Applications (Ophthalmology, Wound Care, Orthopedics, Prenatal Diagnosis, Periodontal, Regenerative Medicine, Stem Cell Biology, and Others), Adherence Type (Without Sutures and With Sutures), End-users (Hospitals, Research Institutes & Academics, Homecare, Clinics, and Others), Distribution Channels (Third-party Distributors and Direct Tenders), and Regions (Asia Pacific, North America, Europe, Latin America, and Middle East & Africa) Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028

  • Report ID: HC-3890
  • Author: Growth Market Reports
  • Rating: 4.8
  • Total Reviews: 2
  • No. Of Pages: 202
  • Format:
  • Pub. Date: Upcoming
  • Share:

The global amniotic products market size was valued at USD 0.7 billion in 2021 and is expected to surpass USD 1.5 billion by 2028. The market is estimated to expand at a CAGR of 8.2% during the forecast period, 2021–2028. Increasing target patient population, rising awareness programs about wound care, treatment & management, growing incidence of burn injuries, and increasing number of amniotic membrane transplantations are factors driving the amniotic products market.


Global Amniotic Products Market summary

Amniotic products, such as amniotic membrane and amniotic fluid products, are tissue derivatives that have been examined and used to treat a variety of orthopedic, ophthalmologic, and cosmetic diseases. These medicines are used to treat retinal detachments, corneal surface lesions, and other ophthalmologic conditions. Amniotic products, such as amniotic membranes, are used by plastic surgeons to treat chronic and acute burns. Amniotic product research has led to the development of treatments for a variety of orthopedic disorders, including osteoarthritis and plantar fasciitis, in the recent years. Amniotic products are being studied as a treatment for a variety of musculoskeletal issues.

Market Trends, Drivers, Restraints, and Opportunities:

  • Increase in incidences of traumatic wounds and rise in orthopedic, ophthalmology, and cosmetic surgeries are expected to boost the market. The number of cases involving burn wounds and injuries has risen dramatically in the recent years. According to the World Health Organization (WHO), burns cause over 180000 deaths each year. The WHO's figures also show that over 1000000 people are moderately or seriously burned every year. These figures highlight the necessity for treatment to lessen the impact of wounds. The need for amniotic products is projected to rise as they are utilized to repair such wounds.
  • Rising number of burn injuries around the globe and increasing awareness programs are anticipated to drive the global amniotic products market in the coming years.
  • Growing venture capital funding and rising government investments are anticipated to drive the market in the coming years.
  • Complications associated with the usage of amniotic membranes are expected to hinder the market during the forecast period.
  • Increasing research in regenerative medicine across the globe is expected to offer lucrative opportunities for key players in the coming years.

Scope of the Report

The report on the global amniotic products market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

                            Attributes                                      

Details

Report Title

Amniotic Products Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2020

Historic Data

2018–2019

Forecast Period

2021–2028

Segmentation

Product Type (Amniotic Suspensions and Amniotic Membranes), Type (Flowable and Non-flowable), Applications (Ophthalmology, Wound Care, Orthopedics, Prenatal Diagnosis, Periodontal, Regenerative Medicine, Stem Cell Biology, and Others), Adherence Type (Without Sutures and With Sutures),  End-users (Hospitals, Research Institutes & Academics, Homecare, Clinics, and Others), Distribution Channels (Third-party Distributors and Direct Tenders)

Regional Scope

Asia Pacific, North America, Latin America, Europe, and Middle East & Africa

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players covered in the Report

MIMEDX., Smith & Nephew, Organogenesis Inc., Integra LifeSciences, AlloSource, Stryker, Katena Products. Inc., Skye Biologics Holdings, LLC, Surgenex, LLC, Ventris Medical, LLC, VIVEX Biologics, Inc., and LifeCell International Pvt. Ltd. 

Global Amniotic Products Market Segment Insights

Based on the product type, the market is divided into amniotic suspensions and amniotic membranes. The amniotic membranes segment is expected to account for a key share of the market during the forecast period owing to the presence of a wide product portfolio provided by various companies.

In terms of type, the amniotic products market is segregated into flowable and non-flowable. The non-flowable segment is projected to account for a considerable share of the market during the forecast period, as it is commonly utilized in wound care and ophthalmology around the globe.


Global Amniotic Products Market type

Based on applications, the market is divided into ophthalmology, wound care, orthopedics, prenatal diagnosis, periodontal, regenerative medicine, stem cell biology, and others. The wound care segment is anticipated to account for a significant share of the market during the forecast period. The anti-inflammatory qualities, bacteriostatic capabilities, wound protection, decreased scarring, pain reduction properties, and epithelialization, make amniotic membrane a desirable method of grafting for wounds. This, in turn, is expected to boost the segment growth in the coming years.


Global Amniotic Products Market applications

In terms of adherence type, the amniotic products market is bifurcated into without sutures and with sutures. The without sutures segment is projected to account for a considerable share of the market during the forecast period as it enables patient compliance, which is expected to boost the demand for amniotic products.

Based on end-uses, the market is classified as hospitals, research institutes & academics, home care, clinics, and others. The hospitals segment is projected to account for a considerable share of the market during the forecast period. Hospitals are primary healthcare provider for amniotic operations. The use of amniotic membrane for ophthalmic use or tendon and ligament repair is largely obtained in hospitals, as they offer reimbursements for the product, thus fueling the segment.

On the basis of distribution channels, the amniotic products market is bifurcated into third-party distributor and direct tender. The third-party distributor segment is projected to account for a considerable share of the market during the forecast period, due to the high demand for amniotic products in hospitals, stores, and clinics, which is expected to increase in the coming years.

Based on regions, the global market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. In 2020, North America held a dominant share of the market for owing to the high prevalence of target diseases, expanding awareness of advanced treatment options, growing elderly population in the region, and presence of a number of prominent market players. Conversely, Asia Pacific is estimated to expand at a high CAGR during the forecast period  due to the presence of several developing countries in the region and expanding their regenerative medicine research. Quick approvals of novel regenerative products/medicines, and implementation of numerous initiatives and acts, are expected to propel the market.


Global Amniotic Products Market region

Segments

Segments Covered in the Report:
By Product Type

  • Amniotic Suspensions
  • Amniotic Membranes

By Type

  • Flowable
  • Non-flowable

By Applications

  • Ophthalmology
  • Wound Care
  • Orthopedics
  • Prenatal Diagnosis
  • Periodontal
  • Regenerative Medicine
  • Stem Cell Biology
  • Others

By Adherence Type

  • Without Sutures
  • With Sutures

By End-Users

  • Hospitals
  • Research Institutes & Academics
  • Homecare
  • Clinics
  • Others

By Distribution Channels

  • Third-party Distributor
  • Direct Tender

By Regions

  • Asia Pacific
  • North America
  • Europe
  • Latin America
  • Middle East &Africa

By Key Players

  • MIMEDX.
  • Smith & Nephew
  • Organogenesis Inc.
  • Integra LifeSciences
  • AlloSource
  • Stryker
  • Katena Products. Inc.
  • Skye Biologics Holdings, LLC
  • Surgenex, LLC
  • Ventris Medical, LLC
  • VIVEX Biologics, Inc.
  • LifeCell International Pvt. Ltd.

 

Competitive Landscape

Players in the global amniotic products market are MIMEDX., Smith & Nephew, Organogenesis Inc., Integra LifeSciences, AlloSource, Stryker, Katena Products. Inc., Skye Biologics Holdings, LLC, Surgenex, LLC, Ventris Medical, LLC, VIVEX Biologics, Inc., and LifeCell International Pvt. Ltd.

Global Amniotic Products Market keyplayers

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Amniotic Products Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Amniotic Products Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Amniotic Products Market - Supply Chain
  4.5. Global Amniotic Products Market Forecast
     4.5.1. Amniotic Products Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Amniotic Products Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Amniotic Products Market Absolute $ Opportunity
5. Global Amniotic Products Market Analysis and Forecast by Types
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Types
     5.2.2. Y-o-Y Growth Projections by Types
  5.3. Amniotic Products Market Size and Volume Forecast by Types
     5.3.1. Flowable
     5.3.2. Non-flowable
  5.4. Absolute $ Opportunity Assessment by Types
  5.5. Market Attractiveness/Growth Potential Analysis by Types
6. Global Amniotic Products Market Analysis and Forecast by Region
  6.1. Market Trends
  6.2. Introduction
     6.2.1. Basis Point Share (BPS) Analysis by Region
     6.2.2. Y-o-Y Growth Projections by Region
  6.3. Amniotic Products Market Size and Volume Forecast by Region
     6.3.1. North America
     6.3.2. Latin America
     6.3.3. Europe
     6.3.4. Asia Pacific
     6.3.5. Middle East and Africa (MEA)
  6.4. Absolute $ Opportunity Assessment by Region
  6.5. Market Attractiveness/Growth Potential Analysis by Region
  6.6. Global Amniotic Products Demand Share Forecast, 2019-2026
7. North America Amniotic Products Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
  7.2. North America Amniotic Products Market Size and Volume Forecast by Country
     7.2.1. U.S.
     7.2.2. Canada
  7.3. Absolute $ Opportunity Assessment by Country
  7.4. North America Amniotic Products Market Size and Volume Forecast by Types
     7.4.1. Flowable
     7.4.2. Non-flowable
  7.5. Basis Point Share (BPS) Analysis by Types
  7.6. Y-o-Y Growth Projections by Types
  7.7. Market Attractiveness/Growth Potential Analysis
     7.7.1. By Country
     7.7.2. By Product Type
     7.7.3. By Application
  7.8. North America Amniotic Products Demand Share Forecast, 2019-2026
8. Latin America Amniotic Products Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Latin America Average Pricing Analysis
  8.2. Latin America Amniotic Products Market Size and Volume Forecast by Country
      8.2.1. Brazil
      8.2.2. Mexico
      8.2.3. Rest of Latin America
   8.3. Absolute $ Opportunity Assessment by Country
  8.4. Latin America Amniotic Products Market Size and Volume Forecast by Types
     8.4.1. Flowable
     8.4.2. Non-flowable
  8.5. Basis Point Share (BPS) Analysis by Types
  8.6. Y-o-Y Growth Projections by Types
  8.7. Market Attractiveness/Growth Potential Analysis
     8.7.1. By Country
     8.7.2. By Product Type
     8.7.3. By Application
  8.8. Latin America Amniotic Products Demand Share Forecast, 2019-2026
9. Europe Amniotic Products Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Europe Average Pricing Analysis
  9.2. Europe Amniotic Products Market Size and Volume Forecast by Country
     9.2.1. Germany
     9.2.2. France
     9.2.3. Italy
     9.2.4. U.K.
     9.2.5. Spain
     9.2.6. Russia
     9.2.7. Rest of Europe
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Europe Amniotic Products Market Size and Volume Forecast by Types
     9.4.1. Flowable
     9.4.2. Non-flowable
  9.5. Basis Point Share (BPS) Analysis by Types
  9.6. Y-o-Y Growth Projections by Types
  9.7. Market Attractiveness/Growth Potential Analysis
     9.7.1. By Country
     9.7.2. By Product Type
     9.7.3. By Application
  9.8. Europe Amniotic Products Demand Share Forecast, 2019-2026
10. Asia Pacific Amniotic Products Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Asia Pacific Average Pricing Analysis
  10.2. Asia Pacific Amniotic Products Market Size and Volume Forecast by Country
     10.2.1. China
     10.2.2. Japan
     10.2.3. South Korea
     10.2.4. India
     10.2.5. Australia
     10.2.6. Rest of Asia Pacific (APAC)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Asia Pacific Amniotic Products Market Size and Volume Forecast by Types
     10.4.1. Flowable
     10.4.2. Non-flowable
  10.5. Basis Point Share (BPS) Analysis by Types
  10.6. Y-o-Y Growth Projections by Types
  10.7. Market Attractiveness/Growth Potential Analysis
     10.7.1. By Country
     10.7.2. By Product Type
     10.7.3. By Application
  10.8. Asia Pacific Amniotic Products Demand Share Forecast, 2019-2026
11. Middle East & Africa Amniotic Products Market Analysis and Forecast
  11.1. Introduction
     11.1.1. Basis Point Share (BPS) Analysis by Country
     11.1.2. Y-o-Y Growth Projections by Country
     11.1.3. Middle East & Africa Average Pricing Analysis
  11.2. Middle East & Africa Amniotic Products Market Size and Volume Forecast by Country
     11.2.1. Saudi Arabia
     11.2.2. South Africa
     11.2.3. UAE
     11.2.4. Rest of Middle East & Africa (MEA)
  11.3. Absolute $ Opportunity Assessment by Country
  11.4. Middle East & Africa Amniotic Products Market Size and Volume Forecast by Types
     11.4.1. Flowable
     11.4.2. Non-flowable
  11.5. Basis Point Share (BPS) Analysis by Types
  11.6. Y-o-Y Growth Projections by Types
  11.7. Market Attractiveness/Growth Potential Analysis
     11.7.1. By Country
     11.7.2. By Product Type
     11.7.3. By Application
  11.8. Middle East & Africa Amniotic Products Demand Share Forecast, 2019-2026
12. Competition Landscape
  12.1. Global Amniotic Products Market: Market Share Analysis
  12.2. Amniotic Products Distributors and Customers
  12.3. Amniotic Products Market: Competitive Dashboard
  12.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     12.4.1. MIMEDX
     12.4.2. Smith & Nephew
     12.4.3. Organogenesis Inc.
     12.4.4. Integra LifeSciences
     12.4.5. AlloSource
     12.4.6. Stryker
     12.4.7. Katena Products. Inc.
     12.4.8. Skye Biologics Holdings, LL

Segments Covered in the Report:
By Product Type

  • Amniotic Suspensions
  • Amniotic Membranes

By Type

  • Flowable
  • Non-flowable

By Applications

  • Ophthalmology
  • Wound Care
  • Orthopedics
  • Prenatal Diagnosis
  • Periodontal
  • Regenerative Medicine
  • Stem Cell Biology
  • Others

By Adherence Type

  • Without Sutures
  • With Sutures

By End-Users

  • Hospitals
  • Research Institutes & Academics
  • Homecare
  • Clinics
  • Others

By Distribution Channels

  • Third-party Distributor
  • Direct Tender

By Regions

  • Asia Pacific
  • North America
  • Europe
  • Latin America
  • Middle East &Africa

By Key Players

  • MIMEDX.
  • Smith & Nephew
  • Organogenesis Inc.
  • Integra LifeSciences
  • AlloSource
  • Stryker
  • Katena Products. Inc.
  • Skye Biologics Holdings, LLC
  • Surgenex, LLC
  • Ventris Medical, LLC
  • VIVEX Biologics, Inc.
  • LifeCell International Pvt. Ltd.

 

Players in the global amniotic products market are MIMEDX., Smith & Nephew, Organogenesis Inc., Integra LifeSciences, AlloSource, Stryker, Katena Products. Inc., Skye Biologics Holdings, LLC, Surgenex, LLC, Ventris Medical, LLC, VIVEX Biologics, Inc., and LifeCell International Pvt. Ltd.

Global Amniotic Products Market keyplayers

Buy Report